Author:
Bjarnadóttir Margrét V.,Malik Sana,Onukwugha Eberechukwu,Gooden Tanisha,Plaisant Catherine
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Pharmacology
Reference28 articles.
1. National Institutes of Health (1997) The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National Institutes of Health; National Heart Lung and Blood Institute, Bethesda, Maryland.
2. Psaty B, Koepsell TW, LoGerfo J, Inui T. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. J Am Med Assoc. 1990;263(12):1653–7.
3. World Health Organization. Adherence to long term therapies: evidence for action. Geneva: Switzerland; 2003.
4. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. Medication compliance and persistence: terminology and definitions. Value Health. 2008;2(1):44–7.
5. Andrade SE, Kahler KH, Frech F, Chan K. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565–74.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献